Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-8.79 Insider Own- Shs Outstand0.99M Perf Week-13.78%
Market Cap0.63M Forward P/E- EPS next Y-1.55 Insider Trans- Shs Float- Perf Month-25.72%
Income-8.65M PEG- EPS next Q-0.76 Inst Own2.23% Short Float- Perf Quarter-83.32%
Sales0.00M P/S- EPS this Y54.32% Inst Trans- Short Ratio0.02 Perf Half Y-86.26%
Book/sh5.74 P/B0.11 EPS next Y64.80% ROA-65.00% Short Interest0.01M Perf Year-88.84%
Cash/sh10.80 P/C0.06 EPS next 5Y- ROE-132.42% 52W Range0.63 - 12.00 Perf YTD-87.11%
Dividend Est.- P/FCF- EPS past 5Y67.35% ROI-152.79% 52W High-94.73% Beta1.86
Dividend TTM- Quick Ratio3.15 Sales past 5Y0.00% Gross Margin- 52W Low0.33% ATR (14)0.10
Dividend Ex-Date- Current Ratio3.15 EPS Y/Y TTM88.12% Oper. Margin0.00% RSI (14)18.37 Volatility7.61% 7.74%
Employees4 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price5.80
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q56.16% Payout- Rel Volume0.09 Prev Close0.66
Sales Surprise- EPS Surprise10.15% Sales Q/Q- EarningsMar 13 AMC Avg Volume614.01K Price0.63
SMA20-20.10% SMA50-57.20% SMA200-84.46% Trades Volume54,890 Change-4.23%
Mar-15-24 10:52AM
Mar-13-24 04:05PM
Mar-07-24 04:05PM
Mar-05-24 08:34AM
08:00AM Loading…
Mar-04-24 08:00AM
Feb-14-24 09:00AM
Feb-08-24 08:00AM
Dec-13-23 08:30AM
Nov-10-23 12:19PM
Nov-08-23 05:46PM
Nov-03-23 08:41AM
Oct-24-23 09:32AM
Oct-02-23 12:25PM
08:30AM Loading…
Aug-09-23 08:30AM
Aug-02-23 04:45PM
Jul-27-23 08:00AM
May-24-23 08:15AM
May-08-23 05:00PM
May-02-23 08:30AM
Mar-22-23 09:13AM
Mar-21-23 08:30AM
Mar-11-23 02:59AM
Mar-08-23 05:08PM
Mar-02-23 04:05PM
Mar-01-23 08:30AM
Feb-22-23 08:39AM
Dec-13-22 08:30AM
Dec-05-22 11:15AM
08:30AM Loading…
Nov-10-22 08:30AM
Nov-03-22 07:00AM
Nov-01-22 08:30AM
Oct-18-22 08:30AM
Sep-13-22 08:30AM
Aug-23-22 01:43PM
Aug-18-22 07:00AM
Aug-11-22 04:30PM
Aug-09-22 04:23PM
Aug-05-22 09:28AM
Jul-28-22 08:30AM
Jul-18-22 11:43AM
Jul-15-22 08:30AM
Jul-06-22 08:30AM
Jun-15-22 04:01PM
Jun-14-22 08:30AM
Jun-10-22 10:23AM
Jun-06-22 11:22AM
May-23-22 08:30AM
May-17-22 08:30AM
May-11-22 11:24AM
Apr-25-22 01:05PM
Mar-24-22 08:30AM
Mar-15-22 08:41AM
Mar-10-22 08:00AM
Mar-01-22 08:00AM
Feb-17-22 08:00AM
Feb-10-22 08:00AM
Feb-08-22 08:30AM
Jan-26-22 08:00AM
Jan-24-22 07:15AM
Dec-15-21 09:00AM
Dec-14-21 08:30AM
Nov-16-21 08:30AM
Nov-11-21 08:30AM
Nov-08-21 08:00AM
Nov-04-21 09:25AM
Nov-02-21 08:30AM
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.